Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?
- PMID: 22302755
- DOI: 10.1161/CIRCRESAHA.111.247452
Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?
Abstract
In the past few years, the crucial role of different micro-RNAs (miRNAs) in the cardiovascular system has been widely recognized. Recently, it was discovered that extracellular miRNAs circulate in the bloodstream and that such circulating miRNAs are remarkably stable. This has raised the possibility that miRNAs may be probed in the circulation and can serve as novel diagnostic markers. Although the precise cellular release mechanisms of miRNAs remain largely unknown, the first studies revealed that these circulating miRNAs may be delivered to recipient cells, where they can regulate translation of target genes. In this review, we will discuss the nature of the stability of miRNAs that circulate in the bloodstream and discuss the available evidence regarding the possible function of these circulating miRNAs in distant cell-to-cell communication. Furthermore, we summarize and discuss the usefulness of circulating miRNAs as biomarkers for a wide range of cardiovascular diseases such as myocardial infarction, heart failure, atherosclerosis, hypertension, and type 2 diabetes mellitus.
Similar articles
-
Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.Front Med. 2014 Dec;8(4):404-18. doi: 10.1007/s11684-014-0379-2. Epub 2014 Dec 1. Front Med. 2014. PMID: 25445171 Review.
-
Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases.Am J Physiol Heart Circ Physiol. 2012 Nov 1;303(9):H1085-95. doi: 10.1152/ajpheart.00191.2012. Epub 2012 Aug 31. Am J Physiol Heart Circ Physiol. 2012. PMID: 22942181 Review.
-
Profiling of circulating microRNAs: from single biomarkers to re-wired networks.Cardiovasc Res. 2012 Mar 15;93(4):555-62. doi: 10.1093/cvr/cvr266. Epub 2011 Oct 25. Cardiovasc Res. 2012. PMID: 22028337 Free PMC article. Review.
-
Circulating miRNAs: reflecting or affecting cardiovascular disease?Curr Hypertens Rep. 2012 Dec;14(6):498-509. doi: 10.1007/s11906-012-0310-7. Curr Hypertens Rep. 2012. PMID: 22996205 Review.
-
Regulatory RNAs and cardiovascular disease - with a special focus on circulating microRNAs.Physiol Res. 2017 Apr 5;66(Suppl 1):S21-S38. doi: 10.33549/physiolres.933588. Physiol Res. 2017. PMID: 28379027 Review.
Cited by
-
Cell-free microRNAs: potential biomarkers in need of standardized reporting.Front Genet. 2013 Apr 19;4:56. doi: 10.3389/fgene.2013.00056. eCollection 2013. Front Genet. 2013. PMID: 23626598 Free PMC article.
-
The evolutionary consequences of interactions between the epigenome, the genome and the environment.Evol Appl. 2024 Jul 23;17(7):e13730. doi: 10.1111/eva.13730. eCollection 2024 Jul. Evol Appl. 2024. PMID: 39050763 Free PMC article. Review.
-
MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms.Circ Res. 2013 Mar 29;112(7):1073-84. doi: 10.1161/CIRCRESAHA.113.300937. Circ Res. 2013. PMID: 23538277 Free PMC article.
-
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.Gastroenterology. 2015 Oct;149(5):1204-1225.e12. doi: 10.1053/j.gastro.2015.07.011. Epub 2015 Jul 26. Gastroenterology. 2015. PMID: 26216839 Free PMC article. Review.
-
MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus).J Transl Med. 2021 Apr 16;19(1):140. doi: 10.1186/s12967-021-02785-7. J Transl Med. 2021. PMID: 33858417 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous